Bayer Healthcare To Provide Over 600,000 Moxifloxacin Tablets To Fight MDR-TB In China
Bayer Healthcare announced on Monday it “has agreed to support the World Health Organization (WHO) and the Stop TB Partnership in the fight against multidrug-resistant tuberculosis (MDR-TB) by making 620,000 tablets of the antibiotic moxifloxacin available to WHO,” according to a Bayer press release. The WHO will provide the antibiotics to China’s national TB program through the Stop TB Partnership’s Global Drug Facility, the release states (8/15).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.